A

Aligos Therapeutics
D

ALGS

18.580
USD
-2.27
(-10.89%)
مغلق
حجم التداول
18,586
الربح لكل سهم
-7
العائد الربحي
-
P/E
-3
حجم السوق
66,663,033
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Aligos Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.